KayPV [KPV 30mg] – 3 Vials – Corey Pauling

Laboratory: Corey Pauling
Form: Subcutaneous injection
Molecule: KPV (Lys-Pro-Val)
Concentration: 10mg/vial
Volume: 3 vials
Research Dosage: 0.5 to 2mg per injection, administered subcutaneously 2 to 3 times per week. KayPV [10mg X 3 Vials] contains KPV, a tripeptide derived from α-MSH and studied for its anti-inflammatory and tissue-protective properties. It may support the regulation of inflammatory responses, recovery following physical stress, tissue protection, and intestinal health, making it particularly relevant to athletes and physically active individuals.

Description and Effects

KAYPV [KPV 10mg / Vial] contains KPV, a naturally occurring tripeptide composed of lysine, proline, and valine, derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). KPV has been studied for its anti-inflammatory properties and its ability to modulate inflammatory signaling pathways. For athletes and physically active individuals, KPV is of particular interest for supporting recovery from physical stress, regulating inflammatory responses, and supporting tissue and intestinal health.

Product Benefits

• Inflammation Management: Supports mechanisms involved in regulating pro-inflammatory signaling and cytokine activity.
• Recovery Support: May support the body's natural recovery processes following physical stress and inflammation associated with intense training.
• Tissue Protection: Research suggests potential protective effects against inflammatory tissue damage.
• Gut Support: Has been studied for its interaction with the PepT1 transporter and its potential to reduce intestinal inflammation and support mucosal integrity.

Usage Guidelines

• Research Dosage: Injectable KPV protocols commonly referenced by HeliMeds range from 0.5 to 2mg per injection, administered subcutaneously 2 to 3 times per week.
• Administration Frequency: Protocols may be adjusted according to individual tolerance and intended application, with administration generally distributed throughout the week.
• Method of Administration: Injectable KPV is administered subcutaneously. Proper sterile technique should be used for peptide administration.

Precautions and Wellness

• Possible Side Effects: Available information suggests generally good tolerability, although temporary injection-site irritation or flushing may occur.
• Immune Considerations: Because KPV may influence inflammatory and immune signaling pathways, additional caution is appropriate in individuals with active infections or immune-related conditions.
• Monitoring: Monitor general tolerance, injection-site reactions, digestive comfort, and any unusual inflammatory or systemic symptoms during use.
• Storage: Store the lyophilized product in a cool, dry place and refrigerate after reconstitution. Protect the reconstituted solution from light.